GALR1 rs5374: What Your Genotype Means
The rs5374 variant is a common single-nucleotide polymorphism situated in the 3' untranslated region of the GALR1 gene, which encodes the galanin receptor type 1. This receptor system is involved in neurochemical signaling pathways that modulate the autonomic stress response and neuroendocrine function. Genetic association studies have explored rs5374 in candidate-gene models of behavioral stress reactivity and substance use, though existing scientific evidence remains preliminary.
What each genotype means
Typical galanin receptor signaling
You carry two copies of the common C allele at rs5374 in the 3-prime untranslated region of the GALR1 gene. Preliminary candidate-gene research has explored this locus for modest variations in neurochemical stress reactivity and substance liability, but findings remain exploratory and unconfirmed by genome-wide association standards. This genotype represents the baseline genetic profile most frequently observed in general population studies.
Carried by approximately 45% of individuals globally, though frequencies vary across ancestries and are lowest in populations where the T allele is more prevalent.
Intermediate stress reactivity profile
You carry one copy of the C allele and one copy of the T allele at rs5374. Limited candidate-gene literature has evaluated this 3-prime UTR variant for possible downstream effects on galanin receptor expression and stress reactivity, including nominal associations with substance use vulnerability. However, evidence remains weak, did not reach statistical significance after multi-test corrections, and does not establish a definitive clinical effect.
Carried by approximately 44% of individuals worldwide, reflecting an overall minor allele frequency of roughly 33%.
Altered galanin receptor expression
You carry two copies of the minor T allele at rs5374 within the GALR1 gene. While small observational studies have examined potential links between this variant and altered stress-pathway reactivity, these nominal associations have not met genome-wide thresholds or been validated across diverse cohorts. Carrying this genotype does not diagnose any condition or definitively alter physiological stress responses on its own.
Carried by approximately 11% of individuals across global populations in 1000 Genomes and gnomAD.
Genetic Characteristics and Genomic Location
The single-nucleotide polymorphism rs5374 represents a single base transition between thymine (T) and cytosine (C) located on chromosome 18. Specifically, rs5374 lies within the 3' untranslated region (3' UTR) of the GALR1 gene. Untranslated regions at the end of messenger RNA transcripts do not code directly for amino acid sequences; instead, they frequently harbor regulatory elements such as microRNA binding targets and polyadenylation signals that regulate transcript stability, translational efficiency, and overall protein expression levels. Because rs5374 is situated within this regulatory domain, molecular hypotheses suggest that variation at this locus could subtly modulate receptor density in target tissues rather than changing the structural conformation of the receptor itself.
Biological Role of the GALR1 Gene
GALR1 encodes galanin receptor 1, an inhibitory G-protein-coupled receptor (GPCR) that binds the neuropeptide galanin. Widely expressed across the central nervous system and peripheral tissues, GalR1 predominantly couples to Gi/Go proteins to inhibit adenylate cyclase activity and suppress neurotransmitter release. In the brain, galanin signaling plays a critical role in homeostatic regulation, pain perception, and the activity of the hypothalamic-pituitary-adrenal (HPA) axis during psychological and physiological stress. By modulating the release of key neurotransmitters such as serotonin and dopamine, GalR1 serves as a functional brake on certain neural circuits, dampening central nervous system hyperreactivity in response to acute and chronic stressors.
Current Scientific Evidence and Associations
Candidate-gene investigations have evaluated rs5374 for potential roles in stress susceptibility, psychiatric vulnerability, and substance dependency. A notable candidate study exploring stress-response genetic variability in African American cohorts observed nominal, uncorrected associations between rs5374 and cocaine addiction vulnerability, although the finding did not retain statistical significance after adjusting for multiple testing. Other clinical evaluations examining complex neuropsychiatric conditions, such as schizophrenia in East Asian cohorts, found no significant independent association between rs5374 allele distributions and disease status. Across the broader scientific landscape, evidence linking rs5374 to altered human phenotypes is considered limited, underpowered, and largely exploratory without definitive genome-wide validation.
Population Distribution and Allele Patterns
The rs5374 polymorphism is common across human populations. In large reference databases such as the 1000 Genomes Project and the Genome Aggregation Database (gnomAD), the minor allele frequency is approximately 0.33 globally. Both the T and C alleles are observed across diverse ancestral groups, with homozygous reference, heterozygous, and homozygous alternative genotypes regularly detected in healthy populations. In East Asian cohorts, the C allele frequency has been reported at approximately 32%, with homozygous T/T and heterozygous C/T genotypes each representing over 40% of tested individuals and homozygous C/C representing around 8% to 10%. This high degree of polymorphism demonstrates that carrying either allele is a normal variation within the human genome.
Clinical Utility and Lifestyle Context
At present, rs5374 has no diagnostic, prognostic, or clinically actionable value. It is neither listed in pharmacogenomic guidelines from the Clinical Pharmacogenetics Implementation Consortium (CPIC) nor recognized by ClinVar as a disease-causing mutation. Complex behavioral traits, psychiatric conditions, and responses to stress are highly polygenic, shaped by hundreds or thousands of genetic variants interacting with childhood development, psychological resilience, and environmental pressures. Individuals should not make medical choices, alter pharmaceutical treatments, or infer personal resilience levels based on their rs5374 genotype. Anyone with health concerns or questions regarding stress management should consult a qualified healthcare professional.
How common is this variant?
The rs5374 variant is a common polymorphism with a global minor allele frequency of approximately 0.33 across 1000 Genomes and gnomAD datasets, with heterozygous and homozygous genotypes regularly observed across diverse ancestral backgrounds.
Frequently asked questions
What is rs5374?
The rs5374 marker is a common single-nucleotide polymorphism located in the 3' untranslated region of the human GALR1 gene on chromosome 18. It represents a normal variation between thymine (T) and cytosine (C) bases found in roughly one-third of chromosomes worldwide.
Does my rs5374 genotype mean I handle stress poorly?
No. While researchers have studied whether GALR1 variants subtly influence stress-related neurochemical pathways, the existing scientific evidence for rs5374 is limited and preliminary. Stress tolerance and emotional health are complex traits driven primarily by environment, social support, lifestyle, and thousands of interacting genetic factors.
Is rs5374 linked to any medical condition?
There are no confirmed clinical disorders directly caused by rs5374. Candidate-gene studies have explored weak, nominal associations with substance use susceptibility or psychiatric disorders, but these statistical signals have not been validated by large genome-wide association studies or clinical genetics guidelines.
Can I use my rs5374 result to change medications?
No. The rs5374 variant does not have actionable pharmacogenomic utility, and major organizations like CPIC do not recommend modifying any therapy based on this marker. Always consult a physician or licensed pharmacist before initiating, adjusting, or stopping any medication.
Sources & further reading
Educational information only, last refreshed 9/10/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs5374?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in GALR1
GALR1 variant interacting epistatically with GAL polymorphisms to modulate physiological resilience and stress axis vulnerability.
Galanin receptor 1 polymorphism associated with altered stress perception and early onset of maladaptive stress coping behaviors.
Polymorphism in the galanin receptor 1 gene linked to stress neurocircuitry adaptation.
Intronic single-nucleotide variant in the galanin receptor 1 gene associated with altered stress-coping neurobiology and addiction vulnerability phenotypes.